[HTML][HTML] Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults
AJ Romero-Olmedo, AR Schulz, S Hochstätter… - Nature …, 2022 - nature.com
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older
adults (> 80 years old, n= 51) and a younger control group (20–53 years old, n= 46) after …
adults (> 80 years old, n= 51) and a younger control group (20–53 years old, n= 46) after …
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults
AJ Romero-Olmedo, AR Schulz… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.
AJ Romero-Olmedo, AR Schulz, S Hochstätter… - Nature …, 2022 - europepmc.org
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …
[引用][C] Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults
AJ Romero-Olmedo, AR Schulz, S Hochstätter… - Nature …, 2022 - cir.nii.ac.jp
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of
BNT162b2 vaccine in previously unresponsive older adults | CiNii Research CiNii 国立情報学 …
BNT162b2 vaccine in previously unresponsive older adults | CiNii Research CiNii 国立情報学 …
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults
AJ Romero-Olmedo, AR Schulz, H Svenja… - Nature …, 2022 - search.proquest.com
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older
adults (> 80 years old, n= 51) and a younger control group (20–53 years old, n= 46) after …
adults (> 80 years old, n= 51) and a younger control group (20–53 years old, n= 46) after …
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.
AJ Romero-Olmedo, AR Schulz, S Hochstätter… - 2022 - cabidigitallibrary.org
Here we compared SARS-CoV-2-specific antibody and T-cell responses between older
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …
adults (> 80 years old, n= 51) and a younger control group (20-53 years old, n= 46) after …